Table of Contents Author Guidelines Submit a Manuscript
Stroke Research and Treatment
Volume 2016, Article ID 8915764, 5 pages
http://dx.doi.org/10.1155/2016/8915764
Research Article

Safety and Efficacy of Acute Clopidogrel Load in Patients with Moderate and Severe Ischemic Strokes

1Department of Neurology, Tulane University School of Medicine, New Orleans, LA, USA
2Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA
3Department of Global Health Management and Policy, Tulane University School of Public Health, New Orleans, LA, USA
4University of South Carolina School of Medicine, Greenville, SC, USA
5Stroke Program, Department of Neurology, Tulane University School of Medicine, New Orleans, LA, USA

Received 14 July 2016; Accepted 14 September 2016

Academic Editor: Graeme J. Hankey

Copyright © 2016 Amir Shaban et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Müller, M. Seyfarth, S. Rüdiger et al., “Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement,” Heart, vol. 85, no. 1, pp. 92–93, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. W. Hochholzer, D. Trenk, D. Frundi et al., “Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention,” Circulation, vol. 111, no. 20, pp. 2560–2564, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. S. C. Johnston, D. R. Gress, W. S. Browner, and S. Sidney, “Short-term prognosis after emergency department diagnosis of TIA,” The Journal of the American Medical Association, vol. 284, no. 22, pp. 2901–2906, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. J. K. Lovett, M. S. Dennis, P. A. Sandercock, J. Bamford, C. P. Warlow, and P. M. Rothwell, “Very early risk of stroke after a first transient ischemic attack,” Stroke, vol. 34, no. 8, pp. e138–e140, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. A. J. Coull, J. K. Lovett, and P. M. Rothwell, “Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services,” British Medical Journal, vol. 328, no. 7435, pp. 326–328, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. P. A. Barber, J. Zhang, A. M. Demchuk, M. D. Hill, and A. M. Buchan, “Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility,” Neurology, vol. 56, no. 8, pp. 1015–1020, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Kennedy, M. D. Hill, K. J. Ryckborst, M. Eliasziw, A. M. Demchuk, and A. M. Buchan, “Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial,” The Lancet Neurology, vol. 6, no. 11, pp. 961–969, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Wang, Y. Wang, X. Zhao et al., “Clopidogrel with aspirin in acute minor stroke or transient ischemic attack,” The New England Journal of Medicine, vol. 369, no. 1, pp. 11–19, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. S. C. Johnston, J. D. Easton, M. Farrant et al., “Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design,” International Journal of Stroke, vol. 8, no. 6, pp. 479–483, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. J. E. Siegler, A. K. Boehme, A. M. Dorsey et al., “A comprehensive stroke center patient registry: advantages, limitations, and lessons learned,” Medical Student Research Journal, vol. 2, no. 2, pp. 21–29, 2013. View at Publisher · View at Google Scholar
  11. H. P. Adams, B. H. Bendixen, L. J. Kappelle et al., “Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment,” Stroke, vol. 24, no. 1, pp. 35–41, 1993. View at Publisher · View at Google Scholar
  12. D. M. Meyer, K. C. Albright, T. A. Allison, and J. C. Grotta, “LOAD: A Pilot Study of the safety of loading of aspirin and clopidogrel in acute ischemic stroke and transient ischemic attack,” Journal of Stroke and Cerebrovascular Diseases, vol. 17, no. 1, pp. 26–29, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. J. E. Siegler, A. K. Boehme, A. D. Kumar, M. A. Gillette, K. C. Albright, and S. Martin-Schild, “What change in the National Institutes of Health Stroke Scale should define neurologic deterioration in acute ischemic stroke?” Journal of Stroke & Cerebrovascular Diseases, vol. 22, no. 5, pp. 675–682, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Tanne, S. E. Kasner, A. M. Demchuk et al., “Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the multicenter rt-PA acute stroke survey,” Circulation, vol. 105, no. 14, pp. 1679–1685, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Lou, A. Safdar, M. Mehdiratta et al., “The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis,” Neurology, vol. 71, no. 18, pp. 1417–1423, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Y. Leung, K. C. Albright, A. K. Boehme et al., “Short-term bleeding events observed with clopidogrel loading in acute ischemic stroke patients,” Journal of Stroke and Cerebrovascular Diseases, vol. 22, no. 7, pp. 1184–1189, 2013. View at Publisher · View at Google Scholar · View at Scopus